A Monmouth Junction specialty pharmaceutical company named two new members to its executive team Thursday.
Tris Pharma, which focuses on technology-based products, hired Sally A. Berry as chief medical officer and Norma Cappetti as vice president of regulatory affairs, it said in a news release.
Berry is a board certified psychiatrist who has worked with companies such as Pfizer and NextWave Pharmaceuticals during her career. Cappetti has more than 30 years in the pharmaceutical industry, including working with Ono Pharma, Celltech Americas and others.
"We are very pleased to welcome Sally and Norma to our management team," Ketan Mehta, CEO and president, said in a statement. "Their experience within the medical/clinical and regulatory environments, as well as with the FDA, will be a tremendous asset to Tris as we continue to execute on our pipeline and partnered products."
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy